about
Fluoxetine counteracts the cognitive and cellular effects of 5-fluorouracil in the rat hippocampus by a mechanism of prevention rather than recoveryCognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study.Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy.Regional brain activation during verbal declarative memory in metastatic breast cancerThe effects of cyclophosphamide on hippocampal cell proliferation and spatial working memory in rat.The Relationship between Visuospatial Memory and Coping Strategies in Breast Cancer Survivors.Breast cancer medications and vision: effects of treatments for early-stage disease.Why, After Chemotherapy, is it Necessary to Assess Memory Using Translational Testing?Chemobrain: a translational challenge for neurotoxicology.Evaluation of multiple neurotoxic outcomes in cancer chemotherapy.Postoperative hormonal therapy prevents recovery of neurological damage after surgery in patients with breast cancer.Chronic physical effects and health care utilization in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group study.Cognitive dysfunction and cancer: which consequences in terms of disease management?An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors.Integrating imaging findings in evaluating the post-chemotherapy brain.Post-intensive care unit syndrome in gynecologic oncology patients.A novel preventive therapy for paclitaxel-induced cognitive deficits: preclinical evidence from C57BL/6 mice.Evidence for acute neurotoxicity after chemotherapy.Tibetan sound meditation for cognitive dysfunction: results of a randomized controlled pilot trial.Cancer's unequal impact on incomes in Norway.Complications neurologiques des traitements anticancéreux
P2860
Q28478915-56FD573C-F412-4B6F-A942-083805EB1827Q30361724-A68271DB-1DB3-40F2-AD35-6C1FDB2B1906Q30499383-58F8CA39-19FC-4082-9D69-8CE9A18E7C0EQ33810520-C10BA0C9-12AF-44A1-9D42-4633AFAE3125Q33952450-5BAB09B0-25B0-4B16-B9F8-9AC51A77F6F4Q35052530-CA8A0074-DDE5-4A1D-83E4-32B5B0BB716BQ35496778-75D61538-9AC8-4552-B2CA-6F5DA8B1DA51Q36440620-7397B5DA-F26E-4630-A668-95B10C57EBD2Q36973578-1EF381A1-F598-4DC1-932C-716A34E26CA7Q37209002-A31D845F-735D-4248-98CC-1961CFB5AF6CQ37314706-477E8585-DE0F-48DF-9EEB-31211217606EQ37325094-704AE627-166F-470B-9F78-702A1F86B6A7Q37831271-8F4B7DED-DDEE-42D4-9803-43E02E438690Q38000038-B5299120-A26D-4BC4-A645-7616DBE352F9Q38119468-EF3E4DBA-3B77-45B5-8807-9EC468836030Q38865981-4D1EEF03-D8BD-4821-A396-32F31DAD473BQ41687599-EA36A2A8-AFA9-4472-A668-089E68329DAEQ42769499-CE5C7942-3003-4A76-B179-29CD8FDCB746Q45958149-116CE8BA-8490-419C-8319-A8F1C36B69B4Q46722627-2C1A0C86-375B-4066-8771-FC559D9DF7ECQ58929158-4C37F710-3658-46DD-BFEB-B7AE4B2DDA06
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Chemobrain: is systemic chemotherapy neurotoxic?
@ast
Chemobrain: is systemic chemotherapy neurotoxic?
@en
Chemobrain: is systemic chemotherapy neurotoxic?
@nl
type
label
Chemobrain: is systemic chemotherapy neurotoxic?
@ast
Chemobrain: is systemic chemotherapy neurotoxic?
@en
Chemobrain: is systemic chemotherapy neurotoxic?
@nl
prefLabel
Chemobrain: is systemic chemotherapy neurotoxic?
@ast
Chemobrain: is systemic chemotherapy neurotoxic?
@en
Chemobrain: is systemic chemotherapy neurotoxic?
@nl
P921
P3181
P1476
Chemobrain: is systemic chemotherapy neurotoxic?
@en
P2093
Dorothée Voillery
Sophie Taillibert
P3181
P356
10.1097/CCO.0B013E3282F0E224
P407
P577
2007-11-01T00:00:00Z